Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator Implantation to Prevent Tachyarrhythmias following Acute Myocardial Infarction (PROTECT-ICD): Trial Protocol, Background and Significance

The ‘Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator Implantation to Prevent Tachyarrhythmias following Acute Myocardial Infarction’ (PROTECT-ICD) trial is an Australian-led multicentre randomised controlled trial targeting prevention of sudden cardiac death...

Full description

Saved in:
Bibliographic Details
Published in:Heart, lung & circulation lung & circulation, 2016-11, Vol.25 (11), p.1055-1062
Main Authors: Zaman, Sarah, MBBS, PhD, Taylor, Andrew J., MBBS, PhD, Stiles, Martin, MBChB, PhD, Chow, Clara, MBBS, PhD, Kovoor, Pramesh, MBBS, PhD
Format: Article
Language:English
Subjects:
Australia
Cardiovascular
Defibrillators, Implantable
Heart Ventricles - physiopathology
Humans
Implantable-cardioverter defibrillator
Multicenter Studies as Topic
Myocardial infarction
Myocardial Infarction - complications
Myocardial Infarction - physiopathology
Myocardial Infarction - therapy
Primary prevention
Randomised controlled trial
Randomized Controlled Trials as Topic
Sudden cardiac death
Tachycardia - etiology
Tachycardia - physiopathology
Tachycardia - prevention & control
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The ‘Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator Implantation to Prevent Tachyarrhythmias following Acute Myocardial Infarction’ (PROTECT-ICD) trial is an Australian-led multicentre randomised controlled trial targeting prevention of sudden cardiac death in patients who have at least moderately reduced cardiac function following a myocardial infarct (MI). The primary objective of the trial is to assess whether electrophysiological study to guide prophylactic implantation of an implantable cardioverter-defibrillator (ICD) early following MI (first 40 days) will lead to a significant reduction in sudden cardiac death and non-fatal arrhythmia. The secondary objective is to assess the utility of cardiac MRI (CMR) in assessing early myocardial characteristics, and its predictive value for both inducible ventricular tachycardia (VT) at EPS and SCD/ non-fatal arrhythmia at follow-up.
ISSN:1443-9506
1444-2892
DOI:10.1016/j.hlc.2016.04.007